CME Group Inc. $CME Position Trimmed by Burling Wealth Partners LLC

Burling Wealth Partners LLC trimmed its stake in CME Group Inc. (NASDAQ:CME) by 8.8% in the second quarter, Holdings Channel.com reports. The firm owned 20,342 shares of the financial services provider’s stock after selling 1,964 shares during the quarter. CME Group comprises 1.0% of Burling Wealth Partners LLC’s portfolio, making the stock its 26th largest holding. Burling Wealth Partners LLC’s holdings in CME Group were worth $5,607,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its position in CME Group by 1.2% in the 1st quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock worth $9,190,661,000 after buying an additional 400,737 shares in the last quarter. Geode Capital Management LLC grew its stake in CME Group by 3.6% in the second quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after purchasing an additional 319,899 shares in the last quarter. Raymond James Financial Inc. grew its stake in CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock valued at $1,091,401,000 after purchasing an additional 363,130 shares in the last quarter. Vontobel Holding Ltd. raised its stake in shares of CME Group by 3.0% during the 2nd quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock worth $804,823,000 after purchasing an additional 84,005 shares in the last quarter. Finally, Fiera Capital Corp raised its stake in shares of CME Group by 1.6% during the 2nd quarter. Fiera Capital Corp now owns 2,790,592 shares of the financial services provider’s stock worth $769,143,000 after purchasing an additional 44,377 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

CME Group Stock Performance

NASDAQ:CME opened at $283.54 on Friday. The firm has a market capitalization of $102.24 billion, a PE ratio of 27.47, a PEG ratio of 4.41 and a beta of 0.38. CME Group Inc. has a 1 year low of $222.56 and a 1 year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm’s fifty day simple moving average is $266.87 and its 200 day simple moving average is $272.73.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. The company had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same period in the prior year, the company earned $2.68 earnings per share. On average, sell-side analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be paid a dividend of $1.25 per share. The ex-dividend date is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is presently 48.45%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research reports. TD Cowen increased their price objective on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday, October 23rd. Jefferies Financial Group decreased their target price on shares of CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research report on Friday, October 10th. UBS Group cut their price target on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a report on Thursday, October 23rd. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a report on Wednesday, October 8th. Finally, Rothschild & Co Redburn raised their target price on CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a report on Thursday, November 6th. Eight equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $287.06.

Insider Transactions at CME Group

In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares of the company’s stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 14,043 shares of company stock worth $3,791,486. Insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.